EX-99.1 2 cdre-20231108xex99d1.htm EX-99.1

Exhibit 99.1

Cadre Holdings Reports Third Quarter 2023 Financial Results

Increased Quarterly Revenue, Net Income, and Gross Margin Sequentially and Year-Over-Year

Second Consecutive Quarter of Record Adjusted EBITDA and Adjusted EBITDA Margin

Expects Record Full-Year 2023 Net Sales Between $477 to $481 Million and Raises 2023 Full-Year Adjusted EBITDA Guidance Range to $82 to $85 Million

JACKSONVILLE, Fla., November 8, 2023 – Cadre Holdings, Inc. (NYSE: CDRE) ("Cadre" or "the Company"), a global leader in the manufacturing and distribution of safety and survivability equipment for first responders, announced today its consolidated operating results for the three and nine months ended September 30, 2023.

Net sales of $125.1 million for the third quarter; net sales of $357.9 million for the nine months ended September 30, 2023
Gross profit margin of 42.8% for the third quarter; gross profit margin of 42.2% for the nine months ended September 30, 2023
Net income of $11.1 million, or $0.29 per diluted share, for the third quarter; net income of $29.0 million, or $0.77 per diluted share, for the nine months ended September 30, 2023
Adjusted EBITDA of $23.7 million for the third quarter; Adjusted EBITDA of $65.1 million for the nine months ended September 30, 2023
Adjusted EBITDA margin of 19.0% for the third quarter; Adjusted EBITDA margin of 18.2% for the nine months ended September 30, 2023
Declared quarterly cash dividend of $0.08 per share in October 2023

“Cadre’s outstanding third quarter is a testament to our team’s continued strategic execution, together with strong, sustained demand for our mission-critical safety and survivability equipment,” said Warren Kanders, CEO and Chairman. “The implementation of the Cadre operating model, focused on constant improvement and the optimization of outcomes, continued to drive our strong financial performance, highlighted by record Adjusted EBITDA margins and gross margins. For the second consecutive quarter, we achieved our highest Adjusted EBITDA in history, while generating increased net sales and net income both sequentially and year-over-year.”

Mr. Kanders added, “We are pleased to once again raise our full year Adjusted EBITDA outlook based on Cadre’s outperformance to date and confidence in our businesses’ fundamentals for the remainder of 2023. In both the US and internationally, we have seen a broad push to prioritize public safety and believe Cadre is ideally positioned to capitalize on these secular tailwinds over the medium and long term. We continue to actively pursue M&A opportunities to either enhance our market dominance or enter attractive, new adjacencies consistent with our key criteria. With entrenched positions in law enforcement, first responder and military markets, we are on pace to deliver record full year net sales in 2023 and remain excited about the opportunity to further grow our leading platform of premium safety brands moving forward.”

Third Quarter and Nine-Month 2023 Operating Results

For the quarter ended September 30, 2023, Cadre generated net sales of $125.1 million, as compared to $111.6 million for the quarter ended September 30, 2022. This increase was primarily the result of higher domestic demand for armor products and large international orders for crowd control products, partially offset by decreased agency demand for hard goods.

For the nine months ended September 30, 2023, Cadre generated net sales of $357.9 million, as compared to $334.2 million for the prior year period, mainly driven by recent acquisitions and higher demand for armor and crowd control products, partially offset by timing for our EOD products.

For the quarter ended September 30, 2023, Cadre generated gross profit of $53.6 million, as compared to $43.7 million for the quarter ended September 30, 2022. For the nine months ended September 30, 2023, Cadre generated gross profit of $151.0 million, as compared to $127.2 million for the prior year period.


Gross profit margin was 42.9% for the quarter ended September 30, 2023, as compared to 39.2% for the quarter ended September 30, 2022. Gross profit margin was 42.2% for the nine months ended September 30, 2023, as compared to 38.0% for the prior year period, mainly driven by favorable pricing and product mix, prior year amortization of inventory step-up related to acquisitions, and productivity, partially offset by inflation.

Net income was $11.1 million for the quarter ended September 30, 2023, as compared to a net income of $4.9 million for the quarter ended September 30, 2022. The increase resulted primarily from the change in year-over-year sales and the increase in gross profit margin.

Net income was $29.0 million for the nine months ended September 30, 2023, as compared to a net loss of $0.8 million for the prior year period, primarily due to the change in year-over-year sales, the increase in gross profit margin, and a decrease in stock-based compensation expense.

Cadre generated $23.7 million of Adjusted EBITDA for the quarter ended September 30, 2023, as compared to $20.7 million for the quarter ended September 30, 2022. Adjusted EBITDA margin was 19.0% for the quarter ended September 30, 2023, as compared to 18.6% for the prior year period.

Cadre generated $65.1 million of Adjusted EBITDA for the nine months ended September 30, 2023, as compared to $53.3 million for the prior year period. Adjusted EBITDA margin was 18.2% for the nine months ended September 30, 2023, as compared to 16.0% for the prior year period.

Product segment gross margin was 44.3% and 43.9% for the third quarter and first nine months of 2023, respectively, compared to 41.6% and 40.2% for the respective prior year periods.

Distribution segment gross margin was 22.7% and 23.3% for the third quarter and first nine months of 2023, respectively, compared to 19.8% and 20.9% for the respective prior year periods.

Liquidity, Cash Flows and Capital Allocation

Cash and cash equivalents increased by $24.1 million from $45.3 million as of December 31, 2022 to $69.4 million as of September 30, 2023.
Total debt decreased by $6.1 million from $149.7 million as of December 31, 2022, to $143.6 million as of September 30, 2023.
Net debt (total debt net of cash and cash equivalents) decreased by $30.3 million from $104.4 million as of December 31, 2022, to $74.2 million as of September 30, 2023.
Capital expenditures totaled $1.8 million for the third quarter and $4.3 million for the nine months ended September 30, 2023, compared with $0.7 million for the third quarter and $3.2 million for the nine months ended September 30, 2022.

Dividend

On October 24, 2023, the Company announced that its Board of Directors declared a quarterly cash dividend of $0.08 per share, or $0.32 per share on an annualized basis. Cadre's dividend payment will be made on November 17, 2023, to shareholders of record as of the close of business on the record date of November 3, 2023. The declaration of any future dividend is subject to the discretion of the Company's Board of Directors.

2023 Outlook Update

As a result of the Company's third-quarter performance and management's outlook for the remainder of the year, Cadre raised the midpoint of its full-year Adjusted EBITDA guidance range and increased net sales guidance. For the full year 2023, Cadre expects to generate net sales in the range of $477 million to $481 million and Adjusted EBITDA in the range of $82 million to $85 million. We expect capital expenditures to be in the range of $7.0 million to $8.0 million.


Conference Call

Cadre management will host a conference call on Wednesday, November 8, 2023, at 5:00 PM EST to discuss the latest corporate developments and financial results. The dial-in number for callers in the US is (888)-510-2553 and the dial-in number for international callers is 646-960-0473. The access code for all callers is 1410384. A live webcast will also be available on the Company’s website at https://www.cadre-holdings.com/.

A replay of the call will be available through November 22, 2023. To access the replay, please dial 800-770-2030 in the U.S. or +1-647-362-9199 if outside the U.S., and then enter the access code 1410384.

About Cadre

Headquartered in Jacksonville, Florida, Cadre is a global leader in the manufacturing and distribution of safety and survivability products for first responders. Cadre's equipment provides critical protection to allow users to safely and securely perform their duties and protect those around them in hazardous or life-threatening situations. The Company's core products include body armor, explosive ordnance disposal equipment, and duty gear. Our highly engineered products are utilized in over 100 countries by federal, state and local law enforcement, fire and rescue professionals, explosive ordnance disposal teams, and emergency medical technicians. Our key brands include Safariland® and Med-Eng®, amongst others.

Use of Non-GAAP Measures

The Company reports its financial results in accordance with U.S. generally accepted accounting principles (“GAAP”). The press release contains the non-GAAP measures: (i) earnings before interest, taxes, other income or expense, depreciation and amortization (“EBITDA”), (ii) adjusted EBITDA, (iii) adjusted EBITDA margin and (iv) last twelve months adjusted EBITDA. The Company believes the presentation of these non-GAAP measures provides useful information for the understanding of its ongoing operations and enables investors to focus on period- over-period operating performance, and thereby enhances the user’s overall understanding of the Company’s current financial performance relative to past performance and provides, along with the nearest GAAP measures, a baseline for modeling future earnings expectations. Non-GAAP measures are reconciled to comparable GAAP financial measures within this press release. The Company cautions that non-GAAP measures should be considered in addition to, but not as a substitute for, the Company’s reported GAAP results. Additionally, the Company notes that there can be no assurance that the above referenced non-GAAP financial measures are comparable to similarly titled financial measures used by other publicly traded companies.

Forward-Looking Statements

Except for historical information, certain matters discussed in this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include but are not limited to all projections and anticipated levels of future performance. Forward-looking statements involve risks, uncertainties and other factors that may cause our actual results to differ materially from those discussed herein. Any number of factors could cause actual results to differ materially from projections or forward-looking statements, including without limitation, changes to global, social and political economic conditions, spending patterns of government agencies, competitive pressures, the impact of acquisitions and related integration activities, logistical challenges related to disruptions and delays, product liability claims, the success of new product introductions, currency exchange rate fluctuations and the risks of doing business in the markets in which we operate, including foreign countries. More information on potential factors that could affect the Company’s financial results are more fully described from time to time in the Company’s public reports filed with the Securities and Exchange Commission, including the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. All forward-looking statements included in this press release are based upon information available to the Company as of the date of this press release, and speak only as of the date hereof. We assume no obligation to update any forward-looking statements to reflect events or circumstances after the date of this press release.

Contact:

Gray Hudkins

Cadre Holdings, Inc.

203-550-7148


gray.hudkins@cadre-holdings.com

Investor Relations:

The IGB Group

Leon Berman / Matt Berkowitz

212-477-8438 / 212-227-7098

lberman@igbir.com / mberkowitz@igbir.com

Media Contact:

Jonathan Keehner / Andrew Siegel

Joele Frank, Wilkinson Brimmer Katcher

212-355-4449


CADRE HOLDINGS, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(Unaudited)

(In thousands, except share and per share amounts)

September 30, 2023

    

December 31, 2022

Assets

 

  

 

  

Current assets

 

  

 

  

Cash and cash equivalents

$

69,412

$

45,286

Accounts receivable, net of allowance for doubtful accounts of $819 and $924, respectively

61,261

64,557

Inventories

 

82,546

 

70,273

Prepaid expenses

 

14,667

 

10,091

Other current assets

 

8,836

 

6,811

Total current assets

 

236,722

 

197,018

Property and equipment, net of accumulated depreciation and amortization of $48,994 and $42,694, respectively

 

43,657

 

45,285

Operating lease assets

6,643

8,489

Deferred tax assets, net

 

2,299

 

2,255

Intangible assets, net

 

44,333

 

50,695

Goodwill

 

81,212

 

81,576

Other assets

 

5,639

 

6,634

Total assets

$

420,505

$

391,952

Liabilities, Mezzanine Equity and Shareholders' Equity

 

  

 

  

Current liabilities

 

  

 

  

Accounts payable

$

30,733

$

23,406

Accrued liabilities

 

38,673

 

38,720

Income tax payable

 

7,049

 

4,584

Liabilities held for sale

Current portion of long-term debt

 

13,251

 

12,211

Total current liabilities

 

89,706

 

78,921

Long-term debt

 

130,309

 

137,476

Long-term operating lease liabilities

3,603

4,965

Deferred tax liabilities

 

5,047

 

3,508

Other liabilities

 

1,843

 

1,192

Total liabilities

 

230,508

 

226,062

Mezzanine equity

 

 

  

Preferred stock ($0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding as of September 30, 2023 and December 31, 2022)

 

 

Shareholders' equity

 

 

  

Common stock ($0.0001 par value, 190,000,000 shares authorized, 37,586,031 and 37,332,271 shares issued and outstanding as of September 30, 2023 and December 31, 2022, respectively)

 

4

 

4

Additional paid-in capital

 

210,543

 

206,540

Accumulated other comprehensive income

 

2,143

 

2,087

Accumulated deficit

 

(22,693)

 

(42,741)

Total shareholders’ equity

 

189,997

 

165,890

Total liabilities, mezzanine equity and shareholders' equity

$

420,505

$

391,952


CADRE HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

(In thousands, except share and per share amounts)

Three Months Ended September 30, 

Nine Months Ended September 30, 

    

2023

    

2022

    

2023

    

2022

Net sales

$

125,114

$

111,554

$

357,949

$

334,192

Cost of goods sold

 

71,511

 

67,814

 

206,981

 

207,042

Gross profit

 

53,603

 

43,740

 

150,968

 

127,150

Operating expenses

 

  

 

  

 

  

 

  

Selling, general and administrative

 

36,314

 

31,732

 

105,615

 

118,431

Restructuring and transaction costs

 

439

 

1,578

 

1,132

 

3,380

Related party expense

 

116

 

112

 

379

 

1,346

Total operating expenses

 

36,869

 

33,422

 

107,126

 

123,157

Operating income

 

16,734

 

10,318

 

43,842

 

3,993

Other expense

 

  

 

  

 

  

 

  

Interest expense

 

(1,073)

 

(1,567)

 

(3,727)

 

(4,496)

Other (expense) income, net

 

(315)

 

(1,851)

 

395

 

(2,812)

Total other expense, net

 

(1,388)

 

(3,418)

 

(3,332)

 

(7,308)

Income (loss) before provision for income taxes

 

15,346

 

6,900

 

40,510

 

(3,315)

(Provision) benefit for income taxes

 

(4,293)

 

(1,959)

 

(11,463)

 

2,536

Net income (loss)

$

11,053

$

4,941

$

29,047

$

(779)

Net income (loss) per share:

 

  

 

  

 

  

 

  

Basic

$

0.29

$

0.13

$

0.77

$

(0.02)

Diluted

$

0.29

$

0.13

$

0.77

$

(0.02)

Weighted average shares outstanding:

 

  

 

  

 

  

 

  

Basic

 

37,586,031

 

37,289,880

 

37,515,976

 

35,697,891

Diluted

 

37,930,888

 

37,747,614

 

37,830,790

 

35,697,891


CADRE HOLDINGS, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

(In thousands)

Nine Months Ended September 30, 

    

2023

    

2022

Cash Flows From Operating Activities:

 

  

 

  

Net income (loss)

$

29,047

$

(779)

Adjustments to reconcile net income (loss) to net cash provided by operating activities:

 

  

 

  

Depreciation and amortization

 

12,385

 

11,319

Amortization of original issue discount and debt issue costs

 

359

 

554

Amortization of inventory step-up

3,055

Deferred income taxes

 

1,317

 

(2,755)

Stock-based compensation

7,060

28,988

Gain on sale of fixed assets

(98)

Provision for losses on accounts receivable

 

37

 

245

Foreign exchange (gain) loss

 

(243)

 

3,006

Other

(296)

Changes in operating assets and liabilities, net of impact of acquisitions:

 

 

Accounts receivable

 

3,429

 

(3,271)

Inventories

 

(12,229)

 

(7,187)

Prepaid expenses and other assets

 

(3,131)

 

986

Accounts payable and other liabilities

 

8,623

 

(4,660)

Net cash provided by operating activities

 

46,260

 

29,501

Cash Flows From Investing Activities:

 

  

 

  

Purchase of property and equipment

 

(4,248)

 

(2,938)

Proceeds from disposition of property and equipment

206

Business acquisitions, net of cash acquired

 

 

(55,039)

Net cash used in investing activities

 

(4,042)

 

(57,977)

Cash Flows From Financing Activities:

 

  

 

  

Proceeds from revolving credit facilities

 

 

43,000

Principal payments on revolving credit facilities

 

 

(43,000)

Principal payments on term loans

 

(7,500)

 

(7,514)

Proceeds from insurance premium financing

3,949

3,989

Principal payments on insurance premium financing

 

(2,909)

 

(3,878)

Payment of capital leases

 

 

(26)

Taxes paid in connection with employee stock transactions

(2,725)

(6,216)

Proceeds from secondary offering, net of underwriter discounts

56,329

Deferred offering costs

(2,953)

Dividends distributed

 

(8,999)

 

(8,521)

Net cash (used in) provided by financing activities

 

(18,184)

 

31,210

Effect of foreign exchange rates on cash and cash equivalents

 

92

 

(241)

Change in cash and cash equivalents

 

24,126

 

2,493

Cash and cash equivalents, beginning of period

 

45,286

 

33,857

Cash and cash equivalents, end of period

$

69,412

$

36,350

Supplemental Disclosure of Cash Flows Information:

Cash paid for income taxes, net

$

7,923

$

710

Cash paid for interest

$

7,389

$

3,860

Supplemental Disclosure of Non-Cash Investing and Financing Activities:

Accruals and accounts payable for capital expenditures

$

24

$

272


CADRE HOLDINGS, INC.

SEGMENT INFORMATION

(Unaudited)

(In thousands)

    

Three Months Ended September 30, 2023

Reconciling

    

Product

Distribution

 Items(1)

    

Total

Net sales

    

$

108,495

    

$

24,208

    

$

(7,589)

    

$

125,114

Cost of goods sold

60,380

18,724

(7,593)

71,511

Gross profit

$

48,115

$

5,484

$

4

$

53,603

    

Three Months Ended September 30, 2022

Reconciling

    

Product

    

Distribution

    

 Items(1)

    

Total

Net sales

    

$

92,718

    

$

26,012

    

$

(7,176)

    

$

111,554

Cost of goods sold

54,125

20,859

(7,170)

67,814

Gross profit

$

38,593

$

5,153

$

(6)

$

43,740

    

Nine Months Ended September 30, 2023

Reconciling

    

    Product    

    

Distribution

    

 Items(1)

    

      Total      

Net sales

    

$

305,057

    

$

74,594

    

$

(21,702)

    

$

357,949

Cost of goods sold

171,204

57,200

(21,423)

206,981

Gross profit

$

133,853

$

17,394

$

(279)

$

150,968

    

Nine Months Ended September 30, 2022

Reconciling

    

    Product    

    

Distribution

    

 Items(1)

    

      Total      

Net sales

    

$

277,941

    

$

73,836

$

(17,585)

    

$

334,192

Cost of goods sold

166,192

$

58,437

$

(17,587)

207,042

Gross profit

$

111,749

$

15,399

$

2

$

127,150


(1)Reconciling items consist primarily of intercompany eliminations and items not directly attributable to operating segments.


CADRE HOLDINGS, INC.

RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES

(Unaudited)

(In thousands)

Year ended

Three Months

Three Months Ended

Nine Months Ended

Last Twelve

December 31, 

Ended June 30,

September 30, 

September 30, 

Months

2022

2023

2023

2022

2023

2022

September 30, 2023

Net income (loss)

$

5,820

$

10,992

$

11,053

$

4,941

$

29,047

$

(779)

$

35,646

Add back:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Depreciation and amortization

 

15,651

 

3,959

 

4,165

 

3,939

 

12,385

 

11,319

 

16,717

Interest expense

 

6,206

 

1,013

 

1,073

 

1,567

 

3,727

 

4,496

 

5,437

Provision (benefit) for income taxes

 

3,553

 

4,229

 

4,293

 

1,959

 

11,463

 

(2,536)

 

17,552

EBITDA

$

31,230

$

20,193

$

20,584

$

12,406

$

56,622

$

12,500

$

75,352

Add back:

 

  

 

  

 

  

 

  

 

  

 

  

 

  

Restructuring and transaction costs(1)

 

5,355

 

693

 

439

 

1,578

 

1,132

 

4,380

 

2,107

Other general income(2)

(159)

(159)

Other expense (income), net(3)

 

1,137

 

(346)

 

315

 

1,851

 

(395)

 

2,812

 

(2,070)

Stock-based compensation expense(4)

32,239

2,105

2,208

2,820

7,060

29,361

9,938

Stock-based compensation payroll tax expense(5)

305

220

305

220

LTIP bonus(6)

 

1,369

 

160

 

185

 

375

 

489

 

933

 

925

Amortization of inventory step-up(7)

4,255

1,711

3,055

1,200

Adjusted EBITDA

$

75,731

$

22,805

$

23,731

$

20,741

$

65,128

$

53,346

$

87,513

Adjusted EBITDA margin(8)

 

16.5

%

 

18.8

%

 

19.0

%

 

18.6

%

 

18.2

%

 

16.0

%

 


(1)Reflects the “Restructuring and transaction costs” line item on our condensed consolidated statement of operations, which primarily includes transaction costs composed of legal and consulting fees, and $1.0 million paid to Kanders & Company, Inc., a company controlled by our Chief Executive Officer, for services related to the acquisition of Cyalume, which is included in related party expense in the Company’s consolidated statements of operations for the year ended December 31, 2022.
(2)Reflects the “Other general income” line item on our condensed consolidated statement of operations and includes a gain from a long-lived asset sale.
(3)Reflects the “Other (income) expense, net” line item on our condensed consolidated statement of operations and primarily includes gains and losses on foreign currency transactions.
(4)Reflects compensation expense related to equity and liability classified stock-based compensation plans.
(5)Reflects payroll taxes associated with vested stock-based compensation awards.
(6)Reflects the cost of a cash-based long-term incentive plan awarded to employees that vests over three years.
(7)Reflects amortization expense related to the step-up inventory adjustment recorded as a result of our recent acquisitions.
(8)Reflects Adjusted EBITDA / Net Sales for the relevant periods.